Detalles de la búsqueda
1.
Fatigue in Prostate Cancer: A Roundtable Discussion and Thematic Literature Review.
Eur Urol Open Sci
; 63: 119-125, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38596782
2.
Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review.
Eur Urol
; 2024 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38782697
3.
How Can We Improve Patient-Clinician Communication for Men Diagnosed with Prostate Cancer?
Eur Urol Open Sci
; 62: 1-7, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38585208
4.
Nonsurgical Interventions to Prevent Disease Progression in Prostate Cancer Patients on Active Surveillance: A Systematic Review and Meta-analysis.
Eur Urol Oncol
; 7(3): 376-400, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38277189
5.
Predictive Models for Assessing Patients' Response to Treatment in Metastatic Prostate Cancer: A Systematic Review.
Eur Urol Open Sci
; 63: 126-135, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38596781
6.
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.
Eur Urol
; 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38614820
7.
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer.
Eur Urol
; 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38688773
8.
Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform.
Eur Urol Open Sci
; 63: 81-88, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572301
9.
Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data.
Eur Urol
; 85(5): 457-465, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414703
10.
Increased use of 6-monthly gonadotropin-releasing hormone agonist therapy for prostate cancer: a capacity and cost-minimization analysis for England.
J Med Econ
; 26(1): 208-218, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36749636
11.
ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer.
Radiother Oncol
; 183: 109544, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36813168
12.
Research protocol to identify progression and death amongst patients with metastatic hormone-sensitive prostate cancer treated with available treatments: PIONEER IMI's "big data for better outcomes" program.
Int J Surg Protoc
; 27(3): 122-129, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38046899
13.
Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.
Eur Urol
; 84(1): 65-85, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37117107
14.
A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer.
Eur Urol Oncol
; 2023 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38151440
15.
Initial experience with AI Pathway Companion: Evaluation of dashboard-enhanced clinical decision making in prostate cancer screening.
PLoS One
; 17(7): e0271183, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35857753
16.
Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.
Eur Urol Oncol
; 5(2): 153-163, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34785188
17.
A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) Methodology.
Cancers (Basel)
; 14(20)2022 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36291905
18.
Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium.
Eur Urol
; 81(5): 503-514, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35184906
19.
Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis.
Eur Urol Focus
; 8(3): 674-689, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33967010
20.
Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review.
Eur Urol Focus
; 8(3): 690-700, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34147405